Medication info
Gloata Tablets 16 mg (Candesartan Cilexetil)

Gloata Tablets 16 mg (Candesartan Cilexetil)

Prescription medicationTabletOral
Ingredient · strength
Candesartan Cilexetil›16mg / 1 tablet
Manufacturer / importer
Kips Biopharma Co., Ltd.
Appearance
Light pink tablets that are round and biconvex on both sides
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201207587 · Approved 2012.10.31 · Insurance code 693200680

Summary

Main use
Treatment of essential hypertension and heart failure with reduced left ventricular systolic function
Who takes it
Adults · Children
Adult dose
This medicine should be taken at the same time every day, regardless of meals. 1. Essential hypertension 1) Adults: The recommended initial and maintenance dose is 8 ∼ 16 mg of candesartan cilexetil, administered orally once daily. If blood pressure is not adequately controlled after 4 weeks of treatment with 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. If blood pressure is still not controlled at this dose, other treatments should be considered. The maximum effect is achieved within 4 weeks of starting treatment. 2) Older adults: No dose adjustment is necessary. 3) Patients with intravascular volume depletion: In patients at increased risk of hypotension, such as those with volume depletion, administer an initial dose of 4 mg with careful monitoring. 4) Patients with renal impairment: The initial dose for patients with renal impairment, including those receiving hemodialysis, is 4 mg; adjust the dose according to the patient's response. Experience with use in patients with severe or end-stage renal impairment (creatinine clearance < 15 mL/min) is limited. 5) Patients with hepatic impairment: The initial dose for patients with mild to moderate hepatic impairment is 2 mg once daily; adjust the dose according to the patient's response. There is no experience with use in patients with severe hepatic impairment. 2. Heart failure 1) Adults: The recommended initial dose is 4 mg once daily. The dose may be doubled at intervals of at least 2 weeks, taking the patient's tolerability into account, up to a maximum of 32 mg once daily. 2) Older adults, patients with intravascular volume depletion, patients with renal impairment, and patients with mild to moderate hepatic impairment: No dose adjustment is necessary.
Child dose
1. Essential hypertension 6) Children: The safety and efficacy in adolescents and children 18 years of age or younger have not been established. 2. Heart failure 3) Children: The safety and efficacy in adolescents and children 18 years of age or younger have not been established.

Ingredients

Manufacturer
Kips Biopharma Co., Ltd.

Efficacy & effects

Treatment of essential hypertension and heart failure with reduced left ventricular systolic function

  • Essential hypertension
  • heart failure
  • impaired left ventricular contraction
  • decreased left ventricular ejection fraction
View approved original text

This medication is used to treat essential hypertension, controlling high blood pressure to protect vascular and heart health. Additionally, it aids patients with heart failure who have impaired left ventricular contraction, especially those who require further treatment with ACE inhibitors or do not tolerate them well. It helps improve heart failure symptoms and supports heart function. In summary, this medicine is used for treating essential hypertension and specific heart failure patients.

How to take

Adult dose

This medicine should be taken at the same time every day, regardless of meals. 1. Essential hypertension 1) Adults: The recommended initial and maintenance dose is 8 ∼ 16 mg of candesartan cilexetil, administered orally once daily. If blood pressure is not adequately controlled after 4 weeks of treatment with 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. If blood pressure is still not controlled at this dose, other treatments should be considered. The maximum effect is achieved within 4 weeks of starting treatment. 2) Older adults: No dose adjustment is necessary. 3) Patients with intravascular volume depletion: In patients at increased risk of hypotension, such as those with volume depletion, administer an initial dose of 4 mg with careful monitoring. 4) Patients with renal impairment: The initial dose for patients with renal impairment, including those receiving hemodialysis, is 4 mg; adjust the dose according to the patient's response. Experience with use in patients with severe or end-stage renal impairment (creatinine clearance < 15 mL/min) is limited. 5) Patients with hepatic impairment: The initial dose for patients with mild to moderate hepatic impairment is 2 mg once daily; adjust the dose according to the patient's response. There is no experience with use in patients with severe hepatic impairment. 2. Heart failure 1) Adults: The recommended initial dose is 4 mg once daily. The dose may be doubled at intervals of at least 2 weeks, taking the patient's tolerability into account, up to a maximum of 32 mg once daily. 2) Older adults, patients with intravascular volume depletion, patients with renal impairment, and patients with mild to moderate hepatic impairment: No dose adjustment is necessary.

Child dose

1. Essential hypertension 6) Children: The safety and efficacy in adolescents and children 18 years of age or younger have not been established. 2. Heart failure 3) Children: The safety and efficacy in adolescents and children 18 years of age or younger have not been established.

Precautions

This medication can cause serious harm to the fetus and newborn if taken during pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. Patients with known allergic reactions to this medication, pregnant or breastfeeding women, patients with severe liver disease or cholestasis, patients with hereditary angioedema, patients with primary hyperaldosteronism, and those with genetic conditions such as lactose intolerance should not take this drug. Elderly patients, those with hyperkalemia, patients with liver disease, patients with heart valve disease, patients with ischemic heart disease, and patients with impaired kidney function should be monitored more cautiously when taking this medication. Common side effects may include dizziness, back pain, respiratory infections, and more. Rarely, serious side effects such as blood disorders, liver dysfunction, and vascular angioedema may occur; if any unusual symptoms arise, consult a healthcare professional immediately. This drug lowers blood pressure, so it's important to have regular blood pressure and blood tests to monitor for excessive drops in blood pressure or deterioration of kidney function. There may be interactions if taken with other hypertension medications, diuretics, or potassium supplements, so patients must inform their doctor or pharmacist about all medications they are taking. Pregnant or breastfeeding women should avoid taking this medication, and if breastfeeding, discontinuation is recommended. Safety for children or adolescents under 18 has not been established, so it is best not to use it. For elderly patients, it is important to adjust doses gradually to prevent excessive drops in blood pressure. Overdose may cause hypotension, dizziness, or rapid heartbeat; in such cases, seek medical attention immediately. This medication should be kept out of reach of children, and it is important to store it in its original packaging to prevent quality issues.

Side effects

  • Dizziness
  • back pain
  • respiratory infection
  • upper respiratory tract infection
  • pharyngitis
  • rhinitis
  • asthenia
  • fever
  • sensory disturbances
  • dyspepsia
Show 69 more
  • gastroenteritis
  • tachycardia
  • palpitations
  • increased creatine kinase
  • hyperglycemia
  • hypertriglyceridemia
  • hyperuricemia
  • myalgia
  • epistaxis
  • anxiety
  • depression
  • drowsiness
  • dyspnea
  • rash
  • increased sweating
  • hematuria
  • hypotension
  • hyperkalemia
  • renal impairment
  • increased creatinine
  • increased urea
  • fatigue
  • peripheral edema
  • chest pain
  • headache
  • bronchitis
  • cough
  • sinusitis
  • nausea
  • abdominal pain
  • diarrhea
  • vomiting
  • arthralgia
  • proteinuria
  • leukopenia
  • neutropenia
  • agranulocytosis
  • hyponatremia
  • hypoglycemia
  • intestinal vascular edema
  • increased liver enzymes
  • hepatitis
  • elevated AST
  • elevated ALT
  • elevated γ-GTP
  • jaundice
  • urticaria
  • pruritus
  • angioedema
  • rhabdomyolysis
  • acute renal failure
  • interstitial pneumonia
  • shock
  • syncope
  • loss of consciousness
  • paralysis
  • hypertonia
  • facial flushing
  • weight gain
  • facial edema
  • thirst
  • sleep disturbances
  • decreased libido
  • forgetfulness
  • decreased appetite
  • increased appetite
  • tinnitus
  • taste disturbance
  • erectile dysfunction

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture. It is also recommended to keep the medicine at a cool room temperature, between 1 to 30 degrees Celsius. Proper storage can help maintain the drug's effectiveness for a longer period.

Appearance and packaging

Appearance

Light pink tablets that are round and biconvex on both sides

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.